Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92236326 | 9223632 | 6 | F | 20130402 | 20160823 | 20130410 | 20160830 | EXP | JP-GLAXOSMITHKLINE-B0881228A | GLAXOSMITHKLINE | 31.43 | YR | F | Y | 0.00000 | 20160830 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92236326 | 9223632 | 1 | PS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | U | U | 20241 | 75 | MG | TABLET | BID | |||||
| 92236326 | 9223632 | 2 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | U | U | 20241 | 350 | MG | TABLET | ||||||
| 92236326 | 9223632 | 3 | SS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Oral | U | 0 | 40 | MG | TABLET | |||||||
| 92236326 | 9223632 | 4 | C | Vegetamin-B | CHLORPROMAZINE HYDROCHLORIDEPHENOBARBITALPROMETHAZINE | 1 | Oral | U | 0 | 1 | DF | TABLET | QD | ||||||
| 92236326 | 9223632 | 5 | C | Rohypnol | FLUNITRAZEPAM | 1 | Unknown | U | 0 | ||||||||||
| 92236326 | 9223632 | 6 | C | SOLANAX | ALPRAZOLAM | 1 | Oral | U | 0 | .8 | MG | TABLET | TID | ||||||
| 92236326 | 9223632 | 7 | C | Phenobal | PHENOBARBITAL | 1 | Oral | U | 0 | ORAL DRUG UNSPECIFIED FORM | |||||||||
| 92236326 | 9223632 | 8 | C | FLUNITRAZEPAM | FLUNITRAZEPAM | 1 | Oral | U | 0 | 2 | MG | QD | |||||||
| 92236326 | 9223632 | 9 | C | Jzoloft | SERTRALINE HYDROCHLORIDE | 1 | Oral | U | 0 | 100 | MG | TABLET | QD | ||||||
| 92236326 | 9223632 | 10 | C | Limas | LITHIUM CARBONATE | 1 | Oral | U | 0 | 200 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92236326 | 9223632 | 1 | Affect lability |
| 92236326 | 9223632 | 2 | Affect lability |
| 92236326 | 9223632 | 3 | Autonomic nervous system imbalance |
| 92236326 | 9223632 | 4 | Insomnia |
| 92236326 | 9223632 | 6 | Anxiety |
| 92236326 | 9223632 | 8 | Insomnia |
| 92236326 | 9223632 | 9 | Depression |
| 92236326 | 9223632 | 10 | Affect lability |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92236326 | 9223632 | HO |
| 92236326 | 9223632 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92236326 | 9223632 | Affect lability | |
| 92236326 | 9223632 | Coma | |
| 92236326 | 9223632 | Depressive symptom | |
| 92236326 | 9223632 | Insomnia | |
| 92236326 | 9223632 | Overdose | |
| 92236326 | 9223632 | Stress | |
| 92236326 | 9223632 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92236326 | 9223632 | 1 | 20120117 | 0 | ||
| 92236326 | 9223632 | 3 | 200704 | 0 |